Actively Recruiting
Multimodal Study of the Human Brain Epilepsy Tissue
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2025-07-03
150
Participants Needed
1
Research Sites
678 weeks
Total Duration
On this page
Sponsors
A
Assistance Publique - Hôpitaux de Paris
Lead Sponsor
I
ICM Co. Ltd.
Collaborating Sponsor
AI-Summary
What this Trial Is About
The TIPI2 study is a blood and tissue collection protocol to create an annotated biorepository to support research in drug-resistant epilepsy. The aim of the study will be to identify new pathophysiological pathways. For this purpose, the investigators will investigate with a multimodal approach blood and brain samples from patients undergoing a surgery for focal drug-resistant epilepsy. The adult patients will be enrolled either during the pre-surgical evaluation or right before the surgery.
CONDITIONS
Official Title
Multimodal Study of the Human Brain Epilepsy Tissue
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 yo or above
- patients with a focal drug-resistant epilepsy
- patients hospitalized for a pre-surgical evaluation or for an epilepsy surgery
- consent obtained from the patient, or legally authorized representative
- affiliated to a social security system
You will not qualify if you...
- None
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Neurology, Epilepsy Unit, Pitié-Salpêtrière Hospital
Paris, France, 75013
Actively Recruiting
Research Team
V
Vincent M. Navarro, MD, PHD
CONTACT
A
Aurélie Ms Hanin, PharmD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here